EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Vortioxetine reduces the development of pain‐related behaviour in a knee osteoarthritis model in rats: Involvement of nerve growth factor (NGF) down‐regulation

Maja Tomić iD, Katarina Nastić iD, Miroslav Dinić iD, Emilija Brdarić iD, Jelena Kotur-Stevuljević iD, Uroš Pecikoza iD, David Pavićević, Ana Micov iD, Danijela Milenković iD, Aleksandar Jovanović iD, Radica Stepanović-Petrović iD

British Journal of Pharmacology · 2024-12 · 181 (24) · 5079-5093

DOI: 10.1111/bph.17342 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Pharmacology, online erschienen am 19.09.2024. Verfasst von Maja Tomić und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, University of Belgrade - Faculty of Pharmacy, Belgrade, Serbia. Hauptthemen laut MEDLINE: Vortioxetine, Nerve Growth Factor, Osteoarthritis, Knee, Duloxetine Hydrochloride. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Science Fund of the Republic of Serbia, Ministry of Science, Technological Development and Innovations of the Republic of Serbia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Purpose Vortioxetine, a multimodal‐acting antidepressant, has recently shown analgesic properties. We aimed to investigate its prophylactic effect in the osteoarthritis (OA) model and gain insights into the underlying molecular mechanisms. Duloxetine was studied as a reference. Experimental Approach In the monoiodoacetate (MIA)‐induced rat model of knee OA, pain‐related behaviour was assessed in weight‐bearing and Von Frey tests. Antidepressants were administered orally once daily for 28 days. Gene expression of pain‐related mediators ( Ngf , Il‐1β , Tnf‐α , Bdnf , and Tac1 encoding substance P) and oxidative stress parameters were determined after completion of the treatment/behavioural testing protocol. Key Results Vortioxetine and duloxetine dose dependently reduced weight‐bearing asymmetry and mechanical hyperalgesia of the paw ipsilateral to the MIA‐injected knee. Vortioxetine reduced the increased Ngf mRNA expression in the MIA‐injected knees to the level in sham‐injected counterparts. It reduced oxidative stress parameters in the affected knees, more effectively in females than males. Duloxetine showed no effect on Ngf mRNA expression and oxidative stress. Both antidepressants decreased mRNA expression of pain‐related mediators in the lumbar L3–L5 ipsilateral DRGs and spinal cords, which were up‐regulated in MIA‐injected rats. This effect was male‐specific. Conclusion and Implications Vortioxetine may be effective against the development of chronic pain in OA. Its antihyperalgesic effect may be mediated, at least in part, by normalization of NGF expression in the affected joint. Decrease of localized oxidative stress and of expression of pain‐related mediators that contribute to central sensitization are also involved in vortioxetine's antihyperalgesic effect, in a sex‐specific pattern.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VortioxetineNerve Growth FactorOsteoarthritis, KneeDuloxetine HydrochlorideDown-RegulationAnimalsMaleFemaleRatsPainSulfidesDisease Models, AnimalIodoacetic AcidBehavior, AnimalOxidative StressAntidepressive AgentsRats, Sprague-DawleyRats, WistarAnalgesicsHyperalgesia

Stichwörter der Autor:innen

duloxetinenerve growth factor (NGF)osteoarthritis painoxidative stresssex differencesvortioxetine

Substanzen

VortioxetineNerve Growth FactorDuloxetine HydrochlorideSulfidesIodoacetic AcidAntidepressive AgentsAnalgesics

Autor:innen und Institutionen

  • Department of Pharmacology, University of Belgrade - Faculty of Pharmacy, Belgrade, Serbia.
  • Group for Probiotics and Microbiota-Host Interaction, Institute of Molecular Genetics and Genetic Engineering (IMGGE), University of Belgrade, Belgrade, Serbia.
  • Department of Medical Biochemistry, University of Belgrade - Faculty of Pharmacy, Belgrade, Serbia.
  • Department of Physics and Mathematics, University of Belgrade - Faculty of Pharmacy, Belgrade, Serbia.
  • Department of Basic and Clinical Sciences, University of Nicosia - Medical School, Nicosia, Cyprus.
  • Center for Neuroscience and Integrative Brain Research (CENIBRE), University of Nicosia - Medical School, Nicosia, Cyprus.

ORCID-Profile: Maja Tomić, Katarina Nastić, Miroslav Dinić, Emilija Brdarić, Jelena Kotur-Stevuljević, Uroš Pecikoza, Ana Micov, Danijela Milenković, Aleksandar Jovanović, Radica Stepanović-Petrović

Förderung

  • Science Fund of the Republic of Serbia
  • Ministry of Science, Technological Development and Innovations of the Republic of Serbia

Zitieren

APA

Tomić, M., Nastić, K., Dinić, M., Brdarić, E., Kotur-Stevuljević, J., Pecikoza, U., Pavićević, D., Micov, A., Milenković, D., Jovanović, A., & Stepanović-Petrović, R. (2024). Vortioxetine reduces the development of pain‐related behaviour in a knee osteoarthritis model in rats: Involvement of nerve growth factor (NGF) down‐regulation. British Journal of Pharmacology, 181(24), 5079-5093. https://doi.org/10.1111/bph.17342

Vancouver

Tomić M, Nastić K, Dinić M, Brdarić E, Kotur-Stevuljević J, Pecikoza U, et al. Vortioxetine reduces the development of pain‐related behaviour in a knee osteoarthritis model in rats: Involvement of nerve growth factor (NGF) down‐regulation. British Journal of Pharmacology. 2024;181(24):5079-5093. doi:10.1111/bph.17342

BibTeX
@article{Tomi2024,
  author = {Tomić, Maja and Nastić, Katarina and Dinić, Miroslav and Brdarić, Emilija and Kotur-Stevuljević, Jelena and Pecikoza, Uroš and Pavićević, David and Micov, Ana and Milenković, Danijela and Jovanović, Aleksandar and Stepanović-Petrović, Radica},
  title = {Vortioxetine reduces the development of pain‐related behaviour in a knee osteoarthritis model in rats: Involvement of nerve growth factor (NGF) down‐regulation},
  journal = {British Journal of Pharmacology},
  year = {2024},
  volume = {181},
  number = {24},
  pages = {5079--5093},
  doi = {10.1111/bph.17342}
}
Kostenlos starten →